Share Price and Basic Stock Data
Last Updated: October 8, 2025, 11:38 pm
| PEG Ratio | 2.23 |
|---|
Analyst Insight & Comprehensive Analysis
BL Kashyap & Sons Ltd, a player in the Construction, Contracting & Engineering sector, currently trades at ₹60.1 with a MarketCap of ₹1,346 Cr. The company’s Price-to-Earnings ratio stands at 83.1, indicating a premium valuation compared to the sector average in India. BL Kashyap’s Return on Equity (ROE) at 2.00% and Return on Capital Employed (ROCE) at 8.08% are below industry benchmarks, suggesting potential inefficiencies in capital utilization. However, the firm’s Operating Profit Margin (OPM) of 8% is in line with peers, reflecting operational stability. With Promoters holding a significant stake of 61.69%, the company enjoys promoter confidence, but the limited presence of institutional investors like FIIs (0.40%) and DIIs (0.88%) raises concerns about external investor interest.
On the positive side, BL Kashyap boasts healthy Reserves of ₹501 Cr, indicating a strong financial base. However, with Borrowings amounting to ₹316 Cr and a Current Capital Cycle (CCC) of 113 days, the company faces liquidity and working capital challenges. The Price-to-Book Value (P/BV) ratio of 2.21x suggests the stock is trading above its book value, potentially limiting upside for investors. Looking ahead, improving operational efficiency and reducing CCC could enhance profitability and investor confidence. Conversely, a further increase in borrowing costs or a slowdown in project execution could pose risks to the company’s financial health and stock performance. In conclusion, investors should closely monitor BL Kashyap’s efforts to enhance operational performance and manage its working capital effectively to navigate potential risks and capitalize on growth opportunities in the sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of BL Kashyap & Sons Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Engineering and Projects Ltd | 62.1 Cr. | 40.2 | 78.2/22.5 | 7.79 | 36.3 | 0.00 % | 20.5 % | 25.9 % | 10.0 |
| Modis Navnirman Ltd | 637 Cr. | 325 | 344/220 | 77.6 | 46.5 | 0.00 % | 12.9 % | 9.88 % | 10.0 |
| Modulex Construction Technologies Ltd | 145 Cr. | 21.0 | 35.7/16.1 | 43.5 | 0.00 % | 2.51 % | 1.54 % | 10.0 | |
| MPDL Ltd | 31.7 Cr. | 42.8 | 92.7/38.0 | 132 | 0.00 % | 2.87 % | 4.16 % | 10.0 | |
| IITL Projects Ltd | 29.9 Cr. | 59.9 | 78.1/34.7 | 2.97 | 0.00 % | 16.6 % | % | 10.0 | |
| Industry Average | 16,063.74 Cr | 262.05 | 44.05 | 129.28 | 0.14% | 16.47% | 23.87% | 21.60 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 289 | 293 | 253 | 276 | 253 | 327 | 324 | 341 | 350 | 267 | 242 | 294 | 336 |
| Expenses | 257 | 272 | 231 | 253 | 228 | 298 | 300 | 308 | 319 | 247 | 236 | 287 | 310 |
| Operating Profit | 32 | 21 | 22 | 23 | 25 | 29 | 24 | 33 | 32 | 20 | 6 | 7 | 26 |
| OPM % | 11% | 7% | 9% | 8% | 10% | 9% | 7% | 10% | 9% | 8% | 3% | 2% | 8% |
| Other Income | 0 | 5 | 9 | -30 | 3 | 1 | 1 | 8 | 9 | 12 | 9 | 15 | 3 |
| Interest | 13 | 13 | 12 | 13 | 11 | 11 | 12 | 15 | 11 | 14 | 10 | 12 | 11 |
| Depreciation | 3 | 3 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 17 | 11 | 16 | -23 | 14 | 17 | 10 | 22 | 27 | 15 | 2 | 7 | 15 |
| Tax % | 30% | 45% | -129% | 41% | 28% | 29% | 31% | -6% | 24% | 38% | 41% | 149% | 26% |
| Net Profit | 12 | 6 | 37 | -32 | 10 | 12 | 7 | 24 | 20 | 9 | 1 | -3 | 11 |
| EPS in Rs | 0.52 | 0.25 | 1.62 | -1.42 | 0.44 | 0.53 | 0.31 | 1.05 | 0.90 | 0.42 | 0.05 | -0.14 | 0.48 |
Last Updated: August 19, 2025, 10:50 pm
Below is a detailed analysis of the quarterly data for BL Kashyap & Sons Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 336.00 Cr.. The value appears strong and on an upward trend. It has increased from 294.00 Cr. (Mar 2025) to 336.00 Cr., marking an increase of 42.00 Cr..
- For Expenses, as of Jun 2025, the value is 310.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 287.00 Cr. (Mar 2025) to 310.00 Cr., marking an increase of 23.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 19.00 Cr..
- For OPM %, as of Jun 2025, the value is 8.00%. The value appears strong and on an upward trend. It has increased from 2.00% (Mar 2025) to 8.00%, marking an increase of 6.00%.
- For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 12.00 Cr..
- For Interest, as of Jun 2025, the value is 11.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 8.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 149.00% (Mar 2025) to 26.00%, marking a decrease of 123.00%.
- For Net Profit, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from -3.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 14.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.48. The value appears strong and on an upward trend. It has increased from -0.14 (Mar 2025) to 0.48, marking an increase of 0.62.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 2:42 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,349 | 834 | 860 | 924 | 1,012 | 769 | 820 | 762 | 1,158 | 1,110 | 1,245 | 1,154 |
| Expenses | 1,296 | 816 | 792 | 834 | 927 | 713 | 799 | 699 | 1,067 | 1,012 | 1,134 | 1,088 |
| Operating Profit | 53 | 19 | 68 | 89 | 85 | 57 | 21 | 63 | 90 | 98 | 110 | 65 |
| OPM % | 4% | 2% | 8% | 10% | 8% | 7% | 3% | 8% | 8% | 9% | 9% | 6% |
| Other Income | -65 | 31 | 23 | 0 | 31 | 5 | -22 | 7 | 41 | -16 | 12 | 45 |
| Interest | 97 | 81 | 82 | 83 | 77 | 59 | 69 | 59 | 55 | 51 | 49 | 47 |
| Depreciation | 23 | 47 | 21 | 13 | 12 | 12 | 12 | 11 | 10 | 10 | 10 | 12 |
| Profit before tax | -132 | -78 | -12 | -6 | 27 | -10 | -82 | -1 | 66 | 21 | 63 | 50 |
| Tax % | -36% | -26% | -48% | -181% | 23% | -34% | -23% | 8,490% | 33% | -7% | 17% | 45% |
| Net Profit | -85 | -58 | -6 | 5 | 21 | -6 | -63 | -58 | 44 | 22 | 53 | 27 |
| EPS in Rs | -4.14 | -2.82 | -0.29 | 0.24 | 0.98 | -0.28 | -2.79 | -2.59 | 1.95 | 0.98 | 2.33 | 1.22 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 31.76% | 89.66% | 183.33% | 320.00% | -128.57% | -950.00% | 7.94% | 175.86% | -50.00% | 140.91% | -49.06% |
| Change in YoY Net Profit Growth (%) | 0.00% | 57.89% | 93.68% | 136.67% | -448.57% | -821.43% | 957.94% | 167.93% | -225.86% | 190.91% | -189.97% |
BL Kashyap & Sons Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 7% |
| 3 Years: | 0% |
| TTM: | -15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 22% |
| 3 Years: | -2% |
| TTM: | -72% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 55% |
| 3 Years: | 39% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 6% |
| 3 Years: | 8% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 2:31 pm
Balance Sheet
Last Updated: July 25, 2025, 1:46 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 21 | 21 | 21 | 22 | 23 | 23 | 23 | 23 | 23 | 23 | 23 |
| Reserves | 444 | 384 | 379 | 414 | 476 | 493 | 436 | 357 | 400 | 422 | 474 | 501 |
| Borrowings | 682 | 762 | 797 | 745 | 605 | 552 | 520 | 519 | 380 | 320 | 310 | 316 |
| Other Liabilities | 695 | 596 | 637 | 595 | 645 | 756 | 839 | 622 | 629 | 531 | 606 | 676 |
| Total Liabilities | 1,841 | 1,762 | 1,833 | 1,774 | 1,748 | 1,824 | 1,818 | 1,520 | 1,432 | 1,295 | 1,412 | 1,516 |
| Fixed Assets | 140 | 90 | 99 | 431 | 414 | 412 | 311 | 236 | 230 | 133 | 154 | 192 |
| CWIP | 117 | 130 | 139 | 95 | 97 | 94 | 95 | 0 | 0 | 0 | 2 | 0 |
| Investments | 299 | 299 | 301 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1,285 | 1,244 | 1,294 | 1,247 | 1,236 | 1,316 | 1,412 | 1,284 | 1,202 | 1,162 | 1,256 | 1,323 |
| Total Assets | 1,841 | 1,762 | 1,833 | 1,774 | 1,748 | 1,824 | 1,818 | 1,520 | 1,432 | 1,295 | 1,412 | 1,516 |
Below is a detailed analysis of the balance sheet data for BL Kashyap & Sons Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 23.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 23.00 Cr..
- For Reserves, as of Mar 2025, the value is 501.00 Cr.. The value appears strong and on an upward trend. It has increased from 474.00 Cr. (Mar 2024) to 501.00 Cr., marking an increase of 27.00 Cr..
- For Borrowings, as of Mar 2025, the value is 316.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 310.00 Cr. (Mar 2024) to 316.00 Cr., marking an increase of 6.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 676.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 606.00 Cr. (Mar 2024) to 676.00 Cr., marking an increase of 70.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,516.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,412.00 Cr. (Mar 2024) to 1,516.00 Cr., marking an increase of 104.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 192.00 Cr.. The value appears strong and on an upward trend. It has increased from 154.00 Cr. (Mar 2024) to 192.00 Cr., marking an increase of 38.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 2.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,323.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,256.00 Cr. (Mar 2024) to 1,323.00 Cr., marking an increase of 67.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,516.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,412.00 Cr. (Mar 2024) to 1,516.00 Cr., marking an increase of 104.00 Cr..
Notably, the Reserves (501.00 Cr.) exceed the Borrowings (316.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -629.00 | -743.00 | -729.00 | -656.00 | -520.00 | -495.00 | -499.00 | -456.00 | -290.00 | -222.00 | -200.00 | -251.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 107 | 169 | 187 | 156 | 127 | 176 | 171 | 210 | 110 | 138 | 111 | 138 |
| Inventory Days | 259 | 414 | 384 | 333 | 261 | 372 | 347 | 201 | 240 | 105 | 130 | |
| Days Payable | 150 | 188 | 163 | 118 | 152 | 170 | 179 | 116 | 140 | 136 | 154 | |
| Cash Conversion Cycle | 215 | 396 | 407 | 371 | 236 | 378 | 339 | 210 | 195 | 238 | 80 | 113 |
| Working Capital Days | 37 | 73 | 94 | 13 | -19 | -7 | 41 | 84 | 41 | 64 | 68 | 94 |
| ROCE % | 4% | 0% | 6% | 7% | 9% | 5% | 2% | 8% | 10% | 14% | 14% | 8% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 1.22 | 2.33 | 0.98 | 1.95 | -2.59 |
| Diluted EPS (Rs.) | 1.22 | 2.33 | 0.98 | 1.95 | -2.59 |
| Cash EPS (Rs.) | 1.77 | 2.79 | 1.41 | 2.41 | -2.10 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 23.23 | 22.02 | 19.73 | 18.76 | 16.82 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 23.23 | 22.02 | 19.73 | 18.76 | 16.82 |
| Revenue From Operations / Share (Rs.) | 51.17 | 55.20 | 49.24 | 51.34 | 33.81 |
| PBDIT / Share (Rs.) | 4.06 | 5.43 | 5.22 | 4.10 | 3.90 |
| PBIT / Share (Rs.) | 3.51 | 4.97 | 4.79 | 3.64 | 3.41 |
| PBT / Share (Rs.) | 2.23 | 2.81 | 0.91 | 2.92 | -0.03 |
| Net Profit / Share (Rs.) | 1.22 | 2.33 | 0.98 | 1.95 | -2.59 |
| NP After MI And SOA / Share (Rs.) | 1.22 | 2.33 | 0.98 | 1.95 | -2.59 |
| PBDIT Margin (%) | 7.92 | 9.84 | 10.60 | 7.99 | 11.54 |
| PBIT Margin (%) | 6.85 | 9.00 | 9.72 | 7.09 | 10.09 |
| PBT Margin (%) | 4.35 | 5.08 | 1.85 | 5.69 | -0.08 |
| Net Profit Margin (%) | 2.38 | 4.22 | 1.99 | 3.79 | -7.66 |
| NP After MI And SOA Margin (%) | 2.38 | 4.22 | 1.99 | 3.79 | -7.66 |
| Return on Networth / Equity (%) | 5.24 | 10.58 | 4.97 | 10.39 | -15.40 |
| Return on Capital Employeed (%) | 11.60 | 17.16 | 18.33 | 12.39 | 10.79 |
| Return On Assets (%) | 1.81 | 3.72 | 1.70 | 3.06 | -3.84 |
| Long Term Debt / Equity (X) | 0.07 | 0.06 | 0.08 | 0.15 | 0.29 |
| Total Debt / Equity (X) | 0.60 | 0.62 | 0.71 | 0.86 | 1.11 |
| Asset Turnover Ratio (%) | 0.78 | 0.91 | 0.81 | 0.76 | 0.44 |
| Current Ratio (X) | 1.40 | 1.37 | 1.36 | 1.21 | 1.27 |
| Quick Ratio (X) | 1.17 | 0.71 | 0.87 | 0.77 | 0.82 |
| Inventory Turnover Ratio (X) | 1.59 | 1.57 | 1.55 | 1.84 | 1.14 |
| Interest Coverage Ratio (X) | 1.93 | 2.51 | 2.29 | 1.69 | 1.48 |
| Interest Coverage Ratio (Post Tax) (X) | 1.19 | 2.08 | 2.13 | 1.10 | 0.32 |
| Enterprise Value (Cr.) | 1439.17 | 1822.80 | 959.52 | 931.69 | 821.69 |
| EV / Net Operating Revenue (X) | 1.25 | 1.46 | 0.86 | 0.80 | 1.08 |
| EV / EBITDA (X) | 15.73 | 14.88 | 8.15 | 10.07 | 9.34 |
| MarketCap / Net Operating Revenue (X) | 1.00 | 1.24 | 0.63 | 0.51 | 0.55 |
| Price / BV (X) | 2.21 | 3.12 | 1.57 | 1.41 | 1.12 |
| Price / Net Operating Revenue (X) | 1.00 | 1.24 | 0.63 | 0.51 | 0.55 |
| EarningsYield | 0.02 | 0.03 | 0.03 | 0.07 | -0.13 |
After reviewing the key financial ratios for BL Kashyap & Sons Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 5. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 5. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.77. This value is below the healthy minimum of 3. It has decreased from 2.79 (Mar 24) to 1.77, marking a decrease of 1.02.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 23.23. It has increased from 22.02 (Mar 24) to 23.23, marking an increase of 1.21.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 23.23. It has increased from 22.02 (Mar 24) to 23.23, marking an increase of 1.21.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 51.17. It has decreased from 55.20 (Mar 24) to 51.17, marking a decrease of 4.03.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 4.06. This value is within the healthy range. It has decreased from 5.43 (Mar 24) to 4.06, marking a decrease of 1.37.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.51. This value is within the healthy range. It has decreased from 4.97 (Mar 24) to 3.51, marking a decrease of 1.46.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.23. This value is within the healthy range. It has decreased from 2.81 (Mar 24) to 2.23, marking a decrease of 0.58.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
- For PBDIT Margin (%), as of Mar 25, the value is 7.92. This value is below the healthy minimum of 10. It has decreased from 9.84 (Mar 24) to 7.92, marking a decrease of 1.92.
- For PBIT Margin (%), as of Mar 25, the value is 6.85. This value is below the healthy minimum of 10. It has decreased from 9.00 (Mar 24) to 6.85, marking a decrease of 2.15.
- For PBT Margin (%), as of Mar 25, the value is 4.35. This value is below the healthy minimum of 10. It has decreased from 5.08 (Mar 24) to 4.35, marking a decrease of 0.73.
- For Net Profit Margin (%), as of Mar 25, the value is 2.38. This value is below the healthy minimum of 5. It has decreased from 4.22 (Mar 24) to 2.38, marking a decrease of 1.84.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.38. This value is below the healthy minimum of 8. It has decreased from 4.22 (Mar 24) to 2.38, marking a decrease of 1.84.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.24. This value is below the healthy minimum of 15. It has decreased from 10.58 (Mar 24) to 5.24, marking a decrease of 5.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.60. This value is within the healthy range. It has decreased from 17.16 (Mar 24) to 11.60, marking a decrease of 5.56.
- For Return On Assets (%), as of Mar 25, the value is 1.81. This value is below the healthy minimum of 5. It has decreased from 3.72 (Mar 24) to 1.81, marking a decrease of 1.91.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.07. This value is below the healthy minimum of 0.2. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.60. This value is within the healthy range. It has decreased from 0.62 (Mar 24) to 0.60, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.78. It has decreased from 0.91 (Mar 24) to 0.78, marking a decrease of 0.13.
- For Current Ratio (X), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 1.5. It has increased from 1.37 (Mar 24) to 1.40, marking an increase of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has increased from 0.71 (Mar 24) to 1.17, marking an increase of 0.46.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 4. It has increased from 1.57 (Mar 24) to 1.59, marking an increase of 0.02.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.93. This value is below the healthy minimum of 3. It has decreased from 2.51 (Mar 24) to 1.93, marking a decrease of 0.58.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 3. It has decreased from 2.08 (Mar 24) to 1.19, marking a decrease of 0.89.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,439.17. It has decreased from 1,822.80 (Mar 24) to 1,439.17, marking a decrease of 383.63.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has decreased from 1.46 (Mar 24) to 1.25, marking a decrease of 0.21.
- For EV / EBITDA (X), as of Mar 25, the value is 15.73. This value exceeds the healthy maximum of 15. It has increased from 14.88 (Mar 24) to 15.73, marking an increase of 0.85.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 1.24 (Mar 24) to 1.00, marking a decrease of 0.24.
- For Price / BV (X), as of Mar 25, the value is 2.21. This value is within the healthy range. It has decreased from 3.12 (Mar 24) to 2.21, marking a decrease of 0.91.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 1.24 (Mar 24) to 1.00, marking a decrease of 0.24.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in BL Kashyap & Sons Ltd:
- Net Profit Margin: 2.38%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.6% (Industry Average ROCE: 16.47%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.24% (Industry Average ROE: 23.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.19
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.17
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 82.3 (Industry average Stock P/E: 44.05)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.6
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.38%
About the Company - Qualitative Analysis
B L Kashyap & Sons Ltd. is a Public Limited Listed company incorporated on 08/05/1989 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1989PLC036148 and registration number is 036148. Currently Company is involved in the business activities of Construction of buildings. Company's Total Operating Revenue is Rs. 1142.30 Cr. and Equity Capital is Rs. 22.54 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Construction, Contracting & Engineering | 409, 4th Floor, New Delhi Delhi 110025 | info@blkashyap.com http://www.blkashyap.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vinod Kashyap | Chairman |
| Mr. Vineet Kashyap | Managing Director |
| Mr. Vikram Kashyap | Joint Managing Director |
| Mr. H N Nanani | Independent Director |
| Ms. Poonam Sangha | Independent Director |
| Mr. Vivek Talwar | Independent Director |
| Mr. Settihalli Basavaraj | Independent Director |
| Mr. Vishal Sharat Ohri | Nominee Director |
FAQ
What is the intrinsic value of BL Kashyap & Sons Ltd?
BL Kashyap & Sons Ltd's intrinsic value (as of 10 October 2025) is 31.16 which is 47.28% lower the current market price of 59.10, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,333 Cr. market cap, FY2025-2026 high/low of 94.0/42.7, reserves of ₹501 Cr, and liabilities of 1,516 Cr.
What is the Market Cap of BL Kashyap & Sons Ltd?
The Market Cap of BL Kashyap & Sons Ltd is 1,333 Cr..
What is the current Stock Price of BL Kashyap & Sons Ltd as on 10 October 2025?
The current stock price of BL Kashyap & Sons Ltd as on 10 October 2025 is 59.1.
What is the High / Low of BL Kashyap & Sons Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of BL Kashyap & Sons Ltd stocks is 94.0/42.7.
What is the Stock P/E of BL Kashyap & Sons Ltd?
The Stock P/E of BL Kashyap & Sons Ltd is 82.3.
What is the Book Value of BL Kashyap & Sons Ltd?
The Book Value of BL Kashyap & Sons Ltd is 23.2.
What is the Dividend Yield of BL Kashyap & Sons Ltd?
The Dividend Yield of BL Kashyap & Sons Ltd is 0.00 %.
What is the ROCE of BL Kashyap & Sons Ltd?
The ROCE of BL Kashyap & Sons Ltd is 8.08 %.
What is the ROE of BL Kashyap & Sons Ltd?
The ROE of BL Kashyap & Sons Ltd is 2.00 %.
What is the Face Value of BL Kashyap & Sons Ltd?
The Face Value of BL Kashyap & Sons Ltd is 1.00.